Myc mouse and anti-ageing therapy

Alic, N.; Partridge, L.

doi:10.1016/j.tem.2015.02.005

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Myc mouse and anti-ageing therapy

MPS-Authors

/persons/resource/persons129348

Partridge, L.
Department Partridge - Biological Mechanisms of Ageing, Max Planck Institute for Biology of Ageing, Max Planck Society;

External Resource

http://www.ncbi.nlm.nih.gov/pubmed/25727046
(Any fulltext)

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Alic, N., & Partridge, L. (2015). Myc mouse and anti-ageing therapy. Trends Endocrinol Metab, 26(4), 163-4. doi:10.1016/j.tem.2015.02.005.

Cite as: https://hdl.handle.net/21.11116/0000-000B-B49A-C

Abstract

Reduction in the expression and activity of a well-known proto-oncogene, Myc, has a beneficial effect on mouse health and survival to old age, in part independently of cancer impact, a recent study reveals. Is this new anti-ageing intervention pointing a way towards new treatments for age-related diseases?